AAAAAA

   
Results: 1-25 | 26-31 |
Results: 26-31/31

Authors: Heerema, NA Sather, HN Ge, J Arthur, DC Hilden, JM Trigg, ME Reaman, GH
Citation: Na. Heerema et al., Cytogenetic studies of infant acute lymphoblastic leukemia: poor prognosisof infants with t(4;11) - a report of the Children's Cancer Group, LEUKEMIA, 13(5), 1999, pp. 679-686

Authors: Reaman, GH Sposto, R Sensel, MG Lange, BJ Feusner, JH Heerema, NA Leonard, M Holmes, EJ Sather, HN Pendergrass, TW Johnstone, HS O'Brien, RT Steinherz, PG Zeltzer, PM Gaynon, PS Trigg, ME Uckun, FM
Citation: Gh. Reaman et al., Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group, J CL ONCOL, 17(2), 1999, pp. 445-455

Authors: Sun, L Goodman, PA Wood, CM Crotty, ML Sensel, M Sather, H Navara, C Nachman, J Steinherz, PG Gaynon, PS Seibel, N Vassilev, A Juran, BD Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of aberrantly spliced oncogenic Ikaros isoforms in childhood acute lymphoblastic leukemia, J CL ONCOL, 17(12), 1999, pp. 3753-3766

Authors: Sun, L Heerema, N Crotty, L Wu, X Navara, C Vassilev, A Sensel, M Reaman, GH Uckun, FM
Citation: L. Sun et al., Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia, P NAS US, 96(2), 1999, pp. 680-685

Authors: Kaleita, TA Reaman, GH MacLean, WE Sather, HN Whitt, JK
Citation: Ta. Kaleita et al., Neurodevelopmental outcome of infants with acute lymphoblastic leukemia - A children's cancer group report, CANCER, 85(8), 1999, pp. 1859-1865

Authors: Waurzyniak, BJ Heerema, N Sensel, MG Gaynon, PS Kraft, P Sather, HN Chelstrom, L Reaman, GH Uckun, FM
Citation: Bj. Waurzyniak et al., Distinct in vivo engraftment and growth patterns of t(1;19)(+)/E2A-PBX1(+)and t(9;22)(+)/BCR-ABL(+) human leukemia cells in SCID mice, LEUK LYMPH, 32(1-2), 1998, pp. 77-87
Risultati: 1-25 | 26-31 |